Latest Regulatory Milestones News

Page 3 of 102
Artrya has converted its largest US customer and first SAPPHIRE Study participant into a five-year commercial agreement, while delaying its planned Coronary Flow FDA submission to strengthen clinical evidence. The Salix rollout is gaining traction, but revenue remains early and scan volumes are undisclosed.
Victor Sage
Victor Sage
26 Oct 2026
Argent BioPharma ended the September quarter with just A$11,000 in cash after A$734,000 of operating outflows, despite retaining A$7.4 million of unused convertible financing capacity. The company is simultaneously expanding its commercial portfolio through NLC antiviral rights and a CannEpil veterinary programme.
Victor Sage
Victor Sage
23 Oct 2026
TMK Energy has secured Mongolian regulatory acceptance for a formal gas discovery at its Gurvantes XXXV Pilot Well Project, opening the next stage toward appraisal, reserves and a potential production licence. The milestone starts a 90-day window for an appraisal program, but no reserves or commercial production figures have yet been established.
Maxwell Dee
Maxwell Dee
20 Oct 2026
Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.
Ada Torres
Ada Torres
19 Oct 2026
Algorae has secured exclusive Australian commercial rights across eight Umedica-branded molecules while separately advancing a Umedica-supplied product towards regulatory approval. The broader arrangement remains partly non-binding, with financial terms undisclosed and TGA approval still pending.
Victor Sage
Victor Sage
19 Oct 2026
Firebrick Pharma has secured Philippine marketing approval for Nasodine Nasal Spray as an over-the-counter antiseptic, opening a potential launch in the 116 million-person market from early 2027. The approval remains subject to post-approval documentation and future revalidation.
Victor Sage
Victor Sage
16 Oct 2026
Kelly Partners Group Holdings has secured conditional ASX approval to delist, clearing a regulatory milestone in its proposed move to Nasdaq. The plan still depends on shareholder approval and the US listing process, with no effective delisting date set.
Claire Turing
Claire Turing
15 Oct 2026
Medical Developments International CEO Brent MacGregor is stepping down after six years, with CFO Anita James taking over as interim CEO from 15 October. The board has begun searching for a permanent successor as MacGregor prepares to return to North America.
Ada Torres
Ada Torres
15 Oct 2026
Javelin Minerals has advanced its proposed all-scrip takeover by FirstAU while securing Eureka’s final mining approval and reporting further gold intersections. The deal offers a broader exploration portfolio, but the loss of Eureka’s processing pathway and a cash runway of about 2.57 quarters remain material constraints.
Maxwell Dee
Maxwell Dee
14 Oct 2026
Alara Resources’ independently audited reserve statement supports about eight more years of production at its Oman copper mine, with 7.70 million tonnes classified as Probable Ore Reserves. The update also reveals the limits of the mine plan: the licence expires before the scheduled mine life ends, while several technical studies remain unfinished.
Maxwell Dee
Maxwell Dee
14 Oct 2026
SkyCity Entertainment Group has secured the right to apply for two New Zealand online casino licences, committing NZ$30 million in licence fees before GST. The company still needs to complete the application process ahead of next year’s planned market opening.
Victor Sage
Victor Sage
13 Oct 2026
Medical Developments International returned to EBIT profitability in FY26 as Penthrox volumes strengthened across Australian hospitals and Europe. The company now faces the less glamorous test of converting regulatory progress into repeatable demand while absorbing weaker Respiratory sales and new amortisation costs.
Ada Torres
Ada Torres
9 Oct 2026

Browse the archive

Full archive